Current status: 832 hESC lines, 3179 hiPSC lines, and 97 clinical studies, and 417 certificates
Monthly statistic from Jun 1, 2022
Posted on June 1, 2022
| total lines | 4011 |
| hESC lines | 832 |
| hiPSC lines | 3179 |
| derivation countries | 43 |
| projects | 234 |
| providers | 725 |
| clinical studies | 97 |
| subclones | 1567 |
| certificates | 417 |
| cell line certificates | 300 |
| project certificates | 117 |